
Chiara Corti: Ranking Oncologists in Social Media – What Could Go Wrong?
Chiara Corti, Clinical Research Fellow at Dana-Farber Cancer Institute, shared a post on X by JAMA Oncology about their paper by Raffaele Giusti et al.:
“Ranking oncologists in social media. What could go wrong?
At a major oncology conference, just 28.3% of posts by featured voices discussed research – while 34.6% were selfies. Of the research posts, 65.3% supportive, only 9.3% critical. SoMe may push engagement over scientific rigor.”
Quoting JAMA Oncology’s post:
“Viewpoint: The rise of social media and AI in oncology has transformed scientific communication but also fuels bias, misinterpretation, and financial conflicts of interest.”
Yan Leyfman, Medical Oncologist, Co-Founder and Executive Director of MedNews Week, shared these posts, adding:
“All things should be taken with a grain of salt. Social media, like any tool, is shaped by how it’s used – whether for purpose, fun, or both. We saw its power and misuse during COVID, and its value ultimately lies in the audience’s ability to discern.
At conferences, SoMe can amplify the most talked-about data and engage broader audiences, but popularity doesn’t always equal impact—important studies can be overlooked. When used thoughtfully, it can be a powerful way to distill complex science without bias, making it accessible to the masses while still preserving rigor.”
Title: The Role of Social Media in Fueling Bias in Oncology
Authors: Raffaele Giusti, Gennaro Daniele, Fotios Loupakis
You can read the Full Article on JAMA Oncology.
More posts featuring Chiara Corti and Yan Leyfman.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023